tm
Seeing Is Believing
tm
Seeing Is Believing
Gemini Therapeutics's activity chart (see below) currently has 12 price targets and 9 ratings on display.
Analysts average stock forecasts to be materialized ratio is 54.55% with an average time for these price targets to be met of 113.82 days.
Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 11-Mar-2022. First documented stock forecast 03-Mar-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Dec-2021
$5
$-14.89 (-74.86%)
$20
4 years 4 months 24 days ago
(11-Mar-2022)
1/2 (50%)
$-10 (-66.67%)
33
Buy Since 15-Dec-2021
$50
$30.11 (151.38%)
4 years 4 months 25 days ago
(11-Mar-2022)
0/2 (0%)
$35 (233.33%)
Buy Since 21-Dec-2021
$10
$-9.89 (-49.72%)
$15
4 years 5 months 1 days ago
(03-Mar-2022)
1/2 (50%)
$-3.4 (-25.37%)
63
Buy Since 03-Mar-2021
$23
4 years 5 months 3 days ago
(01-Mar-2022)
1/1 (100%)
$-136.4 (-85.57%)
313
Buy Since 22-Nov-2021
$11
$-8.89 (-44.70%)
$11
4 years 5 months 7 days ago
(28-Feb-2022)
0/2 (0%)
$-2.6 (-19.12%)
What is GMTX (Gemini Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on GMTX (Gemini Therapeutics) with a proven track record?
Which analyst has the most public recommendations on GMTX (Gemini Therapeutics)?
Which analyst is the currently most bullish on GMTX (Gemini Therapeutics)?
Which analyst is the currently most reserved on GMTX (Gemini Therapeutics)?
